Myeloid neoplasm with histiocytosis and spleen tyrosine kinase fusion responds to fostamatinib

Affiliations

• ¹ The Ohio State University James Comprehensive Cancer Center, Department of Internal Medicine, Division of Hematology/Medical Oncology.
• ² The Ohio State University Wexner Medical Center, Department of Dermatology.
• ³ The Ohio State University Wexner Medical Center, Department of Pathology.
• ⁴ The Ohio State University James Comprehensive Cancer Center.
• ⁵ The Ohio State University James Comprehensive Cancer Center; The Ohio State University Biomedical Sciences Graduate Program.
• ⁶ Foundation Medicine Inc..
• ⁷ The Ohio State University Wexner Medical Center, Department of Pathology; The Ohio State University James Comprehensive Cancer Center; The Ohio State University Biomedical Sciences Graduate Program.
• ⁸ The Ohio State University James Comprehensive Cancer Center, Department of Internal Medicine, Division of Medical Oncology. sameek.roychowdhury@osumc.edu.
• ⁹ Vanderbilt University Medical Center, Department of Internal Medicine, Division of Hematology/Oncology.